Arranta Bio

Arranta Bio LLC is a contract development and manufacturing organization based in Watertown, Massachusetts, with a cGMP manufacturing facility in Gainesville, Florida. Founded in 2019, the company specializes in the development and production of live biotherapeutic products aimed at treating diseases associated with the human microbiome. Arranta Bio provides a range of services including media formulation, fermentation, cell banking, lyophilization, and analytical testing. Additionally, the company offers cGMP services such as primary packaging and drug substance manufacturing. With a focus on supporting innovators in healthcare, Arranta Bio utilizes bacterial fermentation, isolation, drying, and encapsulation techniques to facilitate the development of new therapies, including mRNA vaccines.

Iain Baird

Founder

1 past transactions

Captozyme

Acquisition in 2019
Captozyme Inc., a biotechnology company, develops oxalate-degrading enzyme therapeutic that removes non-nutrient oxalate from the diet and body of patients in need. Its products are used in treating kidney stone and orphan disorder diseases. The company was incorporated in 2016 and is based in Gainesville, Florida. As of November 13, 2019, Captozyme Inc. operates as a subsidiary of Arranta Bio LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.